{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:01:52Z","timestamp":1761580912066},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":3004,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1093\/annonc\/mdr343","type":"journal-article","created":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T20:04:24Z","timestamp":1314734664000},"page":"2152-2154","source":"Crossref","is-referenced-by-count":15,"title":["Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis"],"prefix":"10.1016","volume":"22","author":[{"given":"A.","family":"Thiery-Vuillemin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Montange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kalbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Maurina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Royer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bouchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Curtit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Pivot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1093\/annonc\/mdr343_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00280-007-0498-4","article-title":"A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period","volume":"61","author":"Britten","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdr343_bb0015","first-page":"21","article-title":"Simultaneous determination of seven tyrosine kinase inhibitors by ultra performance liquid chromatography\u2013tandem mass spectrometry (UPLC\/MS-MS)","volume":"23","author":"Bouchet","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"10.1093\/annonc\/mdr343_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdr343_bb0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0091270009347868","article-title":"Pharmacokinetics and safety of sunitinib malate in subjects with impaired renal function","volume":"50","author":"Khosravan","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/annonc\/mdr343_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2010.09990.x","article-title":"Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis","author":"Josephs","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1093\/annonc\/mdr343_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/annonc\/mdn626","article-title":"Pharmacokinetics of sunitinib in hemodialysis","volume":"20","author":"Izzedine","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdr343_bb0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/annonc\/mdn734","article-title":"Treatment of hemodialyzed patient with sunitinib","volume":"20","author":"Reckova","year":"2009","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdr343_bb0045","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2008.10.028","article-title":"Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis","volume":"73","author":"Zastrow","year":"2009","journal-title":"Urology"},{"issue":"2","key":"10.1093\/annonc\/mdr343_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00280-009-1170-y","article-title":"Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic\/pharmacodynamic meta-analysis","volume":"66","author":"Houk","year":"2010","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/9\/2152\/19446147\/mdr343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:13:25Z","timestamp":1624698805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341938370X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S092375341938370X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr343","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}